Mood Disorders

Psychopharmacology

Ketamine and Other Putative Rapid-Acting Antidepressant Medications: What Have They Taught Us about Neurobiology

Saturday, October 27
2:45 PM - 4:00 PM
Location: Tangerine WF1

The off-label use of ketamine has increased dramatically over the last few years. Yet, many questions remain unanswered regarding the drug’s mechanisms of antidepressant action and potential adverse event profile. This session will critically review and synthesize the large and rapidly growing database related to the mechanisms of rapid-onset antidepressant action. This session will focus on translating the most meaningful clinical and preclinical findings in this field to assist in clinical decision making, which will prove critical in attempts to refine or optimize treatment strategies in the future, and aid in discussions with patients.

Gerard Sanacora, MD, PhD

Professor
Yale University
New Haven, Connecticut

Presentation(s):

Send Email for Gerard Sanacora


Assets

Ketamine and Other Putative Rapid-Acting Antidepressant Medications: What Have They Taught Us about Neurobiology



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Ketamine and Other Putative Rapid-Acting Antidepressant Medications: What Have They Taught Us about Neurobiology